Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
SUPN on Nasdaq
Charles W. Newhall III - trading volume in the past year for Supernus Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
130K |
$4.72M |
$36.24 |
Nov 11, 2024 |
Direct |
|
|
Restricted Stock Unit |
0 |
$0 |
$29.06 |
Feb 23, 2024 |
Direct |
Common Stock |
|
Director Stock Option (Right to Buy) |
0 |
|
|
Nov 11, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.